Literature DB >> 20367137

Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma.

Alpana Sharma1, Rehan Khan, Suhasini Joshi, Lalit Kumar, Manoj Sharma.   

Abstract

We have assessed alterations of Th1 and Th2 derived cytokines in the progression of multiple myeloma (MM) by determining their circulatory concentrations in patients with MM and healthy controls and correlated observations with grade and severity of the disease. The study group consisted of 112 subjects: 62 patients with MM and 50 healthy controls. Regarding serum levels of Th1 cytokines, IFN-gamma was significantly lower and IL-2 was non-significantly increased, while regarding levels of Th2 cytokines, IL-4 and IL-10 were significantly elevated. Results of our study indicate that a marked polarization exists toward Th2 cytokines in MM while Th1 cytokines remain suppressed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20367137     DOI: 10.3109/10428191003699563

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  18 in total

1.  Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.

Authors:  Lei Quan; Zhihong Gong; Song Yao; Elisa V Bandera; Gary Zirpoli; Helena Hwang; Michelle Roberts; Gregory Ciupak; Warren Davis; Lara Sucheston; Karen Pawlish; Dana H Bovbjerg; Lina Jandorf; Citadel Cabasag; Jean-Gabriel Coignet; Christine B Ambrosone; Chi-Chen Hong
Journal:  Int J Cancer       Date:  2013-10-08       Impact factor: 7.396

2.  Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.

Authors:  Jessica M S Jutzy; Salma Khan; Malyn May Asuncion-Valenzuela; Terry-Ann M Milford; Kimberly J Payne; Nathan R Wall
Journal:  Cancer Microenviron       Date:  2012-02-10

Review 3.  Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.

Authors:  Camille Guillerey; Kyohei Nakamura; Slavica Vuckovic; Geoffrey R Hill; Mark J Smyth
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

Review 4.  The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma.

Authors:  Nikolaos Giannakoulas; Ioannis Ntanasis-Stathopoulos; Evangelos Terpos
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

Review 5.  Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells.

Authors:  Calogero Vetro; Alessandra Romano; Flavia Ancora; Francesco Coppolino; Maria V Brundo; Salvatore A Raccuia; Fabrizio Puglisi; Daniele Tibullo; Piera La Cava; Cesarina Giallongo; Nunziatina L Parrinello
Journal:  Front Oncol       Date:  2015-05-21       Impact factor: 6.244

6.  Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

Authors:  Arianna Calcinotto; Maurilio Ponzoni; Roberto Ria; Matteo Grioni; Elena Cattaneo; Isabella Villa; Maria Teresa Sabrina Bertilaccio; Marta Chesi; Alessandro Rubinacci; Giovanni Tonon; P Leif Bergsagel; Angelo Vacca; Matteo Bellone
Journal:  Oncoimmunology       Date:  2015-05-07       Impact factor: 8.110

Review 7.  The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.

Authors:  Jillian Poles; Elisa Karhu; Megan McGill; H Reginald McDaniel; John E Lewis
Journal:  J Clin Transl Res       Date:  2021-05-27

Review 8.  Immunological dysregulation in multiple myeloma microenvironment.

Authors:  Alessandra Romano; Concetta Conticello; Maide Cavalli; Calogero Vetro; Alessia La Fauci; Nunziatina Laura Parrinello; Francesco Di Raimondo
Journal:  Biomed Res Int       Date:  2014-06-11       Impact factor: 3.411

9.  Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.

Authors:  Min Wang; Ping Chen; Yan Jia; Na He; Daqi Li; Chunyan Ji; Daoxin Ma
Journal:  Oncotarget       Date:  2015-07-20

10.  Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune Profiling.

Authors:  Benjamin W Teh; Simon J Harrison; Cody Charles Allison; Monica A Slavin; Tim Spelman; Leon J Worth; Karin A Thursky; David Ritchie; Marc Pellegrini
Journal:  Front Immunol       Date:  2017-10-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.